pentobarbital will minimize the level or effect of etravirine by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Check.
pentobarbital will decrease the level or outcome of estrogens esterified by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Monitor.
pentobarbital will decrease the level or result of almotriptan by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Use Warning/Monitor.
pentobarbital will lower the level or influence of clozapine by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Use Warning/Keep track of.
CYP3A4 inducers could boost the development on the neurotoxic/nephrotoxic ifosfamide metabolite, chloroacetaldehyde. Closely watch sufferers having ifosfamide with CYP3A4 inducers for toxicities and look at dose adjustment.
Contraindicated (one)pentobarbital will minimize the extent or influence of dienogest/estradiol valerate by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Contraindicated. Girls should not select estradiol valerate/dienogest as their contraceptive whilst making use of powerful CYP3A4 inducers on account of likely reduce in contraceptive efficacy.
fentanyl transdermal and pentobarbital both of those improve sedation. Prevent or Use Alternate Drug. Restrict use to patients for whom alternative procedure choices are insufficient
Contraindicated (1)pentobarbital will minimize the level or result of lumacaftor/ivacaftor by influencing hepatic/intestinal enzyme CYP3A4 metabolism.
pentobarbital will decrease website the extent or result of stiripentol by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Stay away from or Use Alternate Drug. If not able to prevent coadministration of stiripentol with robust CYP3A4 inducers, enhance stiripentol dose.
pentobarbital will minimize the level or outcome of atogepant by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Modify Therapy/Check Intently. Advisable atogepant dosage with concomitant use of solid or moderate CYP3A4 inducers is thirty mg or sixty mg qDay.
Contraindicated (1)pentobarbital will lower the extent or impact of lorlatinib by affecting hepatic/intestinal enzyme CYP3A4 metabolism.
pentobarbital will minimize the extent or effect of felodipine by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Use Warning/Check.
Likely for Fake positive examination final results if macimorelin and robust CYP3A4 inducers are coadministered. Discontinue potent CYP3A4 inducer, permitting for adequate washout time, in advance of screening.
pentobarbital will lower the level or impact of ziprasidone by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Small/Importance Not known.